Bristol-Myers to buy private cancer drugmaker for up to $1.25 bln
February 23, 2015 at 08:10 AM EST
Feb 23 (Reuters) - Bristol-Myers Squibb Co said it would buy privately held drugmaker Flexus Biosciences Inc for up to $1.25 billion to expand its pipeline of cancer drugs.
